Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - GROSS PROFIT
Gross Profit IKT - Inhibikase Therapeutics, Inc.
-13.4 M
LAST VALUE
-27.18%
2 YEAR CAGR
-103.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR